These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2688129)

  • 21. Estrogen dependence of primary breast cancer--correlation with histologic type and grade.
    Nikolić-Vukosavljević D; Branković-Magić M; Polić D; Vlajić M; Vuletić L; Spuzić I
    Neoplasma; 1992; 39(5):299-304. PubMed ID: 1436244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
    Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
    Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone receptor modulation in xenotransplanted endocrine related human breast cancer.
    Michel RT; Vering A; Fortmeyer HP; Stegmüller M
    Strahlenther Onkol; 1989 Jul; 165(7):497-8. PubMed ID: 2749477
    [No Abstract]   [Full Text] [Related]  

  • 24. Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer.
    Hinton CP; Roebuck EJ; Williams MR; Blamey RW; Glaves J; Nicholson RI; Griffiths K
    AJR Am J Roentgenol; 1985 Jun; 144(6):1103-7. PubMed ID: 3873788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary breast carcinoma: association of mammographic calcifications with osteopontin expression.
    Wang X; Chao L; Ma G; Chen L; Jin G; Hua M; Liu H; Ouyang A; Zhang X
    Radiology; 2010 Jan; 254(1):69-78. PubMed ID: 20019131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of estrogen, progesterone, and androgen receptors in breast cancer.
    Ellis LM; Wittliff JL; Bryant MS; Hogancamp WE; Sitren HS; Bland KI
    Am J Surg; 1989 Jun; 157(6):577-80; discussion 581. PubMed ID: 2499206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.
    Garcia M; Lacombe MJ; Duplay H; Cavailles V; Derocq D; Delarue JC; Krebs B; Contesso G; Sancho-Garnier H; Richer G
    J Steroid Biochem; 1987; 27(1-3):439-45. PubMed ID: 3320536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast cancer--topics from basic research].
    Matsumoto K; Kuroda H; Takeyama M
    Gan To Kagaku Ryoho; 1984 May; 11(5):974-80. PubMed ID: 6721515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Steroid hormone receptors in breast cancer].
    Moyano C; Puga J; Calaf G; Rojas C
    Rev Chil Obstet Ginecol; 1984; 49(1):15-25. PubMed ID: 6099905
    [No Abstract]   [Full Text] [Related]  

  • 34. [Breast cancer and hormone receptors (author's transl)].
    Matsumoto K
    Horumon To Rinsho; 1980 Jan; 28(1):29-37. PubMed ID: 6989525
    [No Abstract]   [Full Text] [Related]  

  • 35. HER2-positive breast cancer patients: correlation between mammographic and pathological findings.
    Radenkovic S; Konjevic G; Isakovic A; Stevanovic P; Gopcevic K; Jurisic V
    Radiat Prot Dosimetry; 2014 Nov; 162(1-2):125-8. PubMed ID: 25063784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.
    Bhatavdekar JM; Patel DD; Karelia NH; Trivedi SN; Shah NG; Vora HH; Ghosh N; Balar DB
    Neoplasma; 1992; 39(6):349-52. PubMed ID: 1491724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic features of local recurrence after conservative surgery and radiation therapy: comparison with that of the primary tumor.
    Günhan-Bilgen I; Oktay A
    Acta Radiol; 2007 May; 48(4):390-7. PubMed ID: 17453518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a correlation between breast cancer molecular subtype using receptors as surrogates and mammographic appearance?
    Killelea BK; Chagpar AB; Bishop J; Horowitz NR; Christy C; Tsangaris T; Raghu M; Lannin DR
    Ann Surg Oncol; 2013 Oct; 20(10):3247-53. PubMed ID: 23975299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.